In a year of remarkable progress for the Parkinson’s field, we’re entering a new era for better understanding the biology of the disease, with the identification of a breakthrough biomarker accelerating new therapeutics through the clinical pipeline and legislators on Capitol Hill moving toward legislation uniting the federal government in treating, preventing and ultimately curing Parkinson’s disease.
What does this progress mean for researchers studying Parkinson’s and for those living with the disease? And what will come next?
Tune in as scientists and staff from The Michael J. Fox Foundation (MJFF) answer these questions and share insights in our latest Third Thursdays Webinar. Maggie Kuhl, vice president of research engagement at MJFF, leads the discussion with MJFF’s chief program officer Sohini Chowdhury and co-chief science officers Brian Fiske, PhD, and Mark Frasier, PhD, on why 2023 has been so transformative, and why the field is now on the cusp of a new era.
If you’d rather listen on the go, subscribe to our Michael J. Fox Foundation Parkinson's Podcast on iTunes or through any podcast app on your smartphone or tablet. If you enjoyed what you heard, share it with a friend or leave a review on iTunes. It helps listeners like you find and support our mission.
Join a study today to help speed progress toward better treatments and a cure for Parkinson’s disease. To search for studies in your area, visit Fox Trial Finder.
Whether you have Parkinson’s or not, you can help move research forward. Join the study that’s changing everything.